Browse CATs

Browse CATs  internal medicine  cardiology  deep vein thrombosis

Diagnosis Economics Harm/ aetiology Prognosis Therapy

Deep vein thrombosis outpatient anticoagulation was cheaper than inpatient. Level of evidence 1b Expiry Date February 2003 Deep vein thrombosis LMWH was more cost-effective than heparin. Level of evidence 1b Expiry Date May 2003 Deep vein thrombosis prophylaxis: LMWH and warfarin were equally cost-effective in patients undergoing hip or knee replacement. Level of evidence 1b Expiry Date May 2003 Deep vein thrombosis treatment with enoxaparin or unfractionated heparin cost the same Level of evidence 1b Expiry Date November 2003 Venous thromboembolism compression stockings were most cost-effective. Level of evidence 2b Expiry Date December 2003 Venous thromboembolism prophylaxis: LMWH may be cost-effective for abdominal and hip surgery. Level of evidence 2b Expiry Date June 2003